What role does Cardio Risk Check play in menopause?

The Cardio Risk Check is a test panel that typically includes biomarkers such as cholesterol, inflammatory markers, and sometimes genetic variants. During menopause, cardiovascular risk increases due to declining estrogen levels, which can worsen lipid profiles and increase arterial stiffness. The test may help identify this elevated risk early and guide personalized lifestyle interventions like diet and exercise. However, the evidence for the direct benefit of such checks in menopause is limited – many markers are not highly specific, and the predictive power for individual events is moderate. Moreover, long-term studies proving that test-guided interventions actually prevent heart attacks or strokes are lacking. Therefore, the test should be seen as complementary information, not a standalone decision tool. Medical consultation remains essential.